Why Magnesium Became a Popular Sleep Supplement
Magnesium is involved in hundreds of enzymatic reactions and contributes to normal neuromuscular function. Proposed sleep related mechanisms include effects on neuronal excitability, inhibitory neurotransmission and muscle relaxation.
Those mechanisms make the idea scientifically plausible. They do not, however, tell us whether giving additional magnesium to someone who already has adequate magnesium status will meaningfully improve sleep.
That distinction matters because observational studies and supplementation trials answer different questions.
Observational research has sometimes found associations between magnesium intake or magnesium status and better sleep. But people who consume more magnesium may also eat differently, exercise more, or have other health behaviors that influence sleep. Randomized trials are therefore much more informative when asking whether taking a supplement itself causes better sleep.
And the randomized evidence is far less consistent. The U.S. National Center for Complementary and Integrative Health has historically characterized the research on magnesium for insomnia as limited and conflicting.
What the Newer Trials Actually Found
One of the stronger recent trials evaluated magnesium bisglycinate in 155 adults reporting poor sleep.
Participants received 250 mg of elemental magnesium daily or placebo for four weeks. Insomnia Severity Index scores improved in both groups, but the magnesium group improved slightly more. The betweengroup effect size was only Cohen's d = 0.2, which is considered small. Other secondary psychological and sleep-related outcomes did not show consistent significant differences.
Importantly, this study was academically funded rather than directly funded by a supplement company, although one author disclosed professional relationships with nutraceutical companies.
Magnesium L-threonate has also received considerable attention.
A 2024 randomized trial involving 80 adults with self-reported sleep problems reported improvements in several subjective and wearable-derived sleep measures after three weeks of magnesium L-threonate. However, that research was funded by AIDP Inc., a company associated with the ingredient being studied.
A separate 2026 placebo-controlled trial of 100 adults produced a more mixed result. Magnesium L-threonate improved one measure of sleep-related impairment, but there were no significant between-group improvements in general sleep disturbance, restorative sleep, sleep duration, deep sleep, sleep efficiency or other major objective sleep outcomes recorded by an Oura Ring. The trial was funded by Threotech Inc., which also provided the investigational product and participated in study conceptualization.
Taken together, these studies suggest a possible signal but not the kind of consistent effect we would expect from a reliably effective insomnia treatment.
Is Magnesium Glycinate Better Than Other Forms for Sleep?
This is where marketing currently runs ahead of the science.
Magnesium glycinate or bisglycinate is frequently promoted specifically for sleep. A randomized 2025 trial provides some direct evidence for bisglycinate, but it is still essentially one substantial trial showing a small benefit.
Magnesium L-threonate has also been marketed around brain penetration and neurological benefits. Some trials are encouraging, but results across subjective and objective sleep outcomes have not been consistent.
The August 2026 systematic review is particularly important because it looked across formulations rather than focusing on a single commercial ingredient. It found substantial differences in magnesium formulation, elemental dose, treatment duration and measurement methods, making the studies difficult to compare directly.
There is therefore not enough comparative evidence to say that magnesium glycinate, bisglycinate or L-threonate is clearly the best form for sleep.
Claims such as “glycinate is the sleep form” or “L-threonate is uniquely effective because it reaches the brain” should currently be treated as stronger than the clinical evidence supports.
Magnesium Is Not Risk-Free Just Because It Is a Mineral
Magnesium from normal foods is not generally a toxicity concern in healthy people because excess magnesium can be excreted by the kidneys.
Supplemental magnesium is different.
The U.S. National Institutes of Health sets the adult tolerable upper intake level for magnesium from supplements and medications at 350 mg per day. This limit does not include magnesium naturally present in food. Higher supplemental intakes commonly cause diarrhea, nausea or abdominal cramping.
People with significantly impaired kidney function require particular caution because reduced renal clearance increases the risk of magnesium accumulation and toxicity.
Magnesium can also interfere with the absorption of some medications. NIH specifically notes interactions with certain antibiotics and oral bisphosphonates, among others.
And dietary supplements are not evaluated by the FDA for effectiveness before they reach the U.S. market in the same way that approved medications are.